Skip to main content
. 2020 Nov 11;17:53. doi: 10.1186/s12970-020-00386-1

Table 4.

Changes of myoglobin [ng/ml] concentration in study participants sera

SE SC OE OC p (between groups)
Test I 1 h before 26.13 ± 10.08 25.21 ± 6.48 18.65 ± 8.19 25.63 ± 8.22 0.295
1 h after 143.0 ± 78.40 196.2 ± 111.3 126.6 ± 60.2 129.8 ± 51.41 0.544
24 h after 34.45 ± 10.02 35.22 ± 20.06 31.95 ± 17.17 46.96 ± 18.48 0.122
p (inside.groups) 0.000 0.009 0.002 0.001
Test II 1 h before 25.52 ± 18.73 34.29 ± 12.32 45.24 ± 27.35 25.48 ± 11.02 0.180
1 h after 71.65 ± 43.45 133.5 ± 53.66 75.33 ± 47.03 141.8 ± 85.32 0.099
24 h after 45.91 ± 31.71 33.46 ± 17.71 21.42 ± 13.48 57.95 ± 51.27 0.874
p (inside.groups) 0.001 0.011 0.004 0.006
p (Test I vs. Test II) 1 h before 0.575 0,116 0.398 1.000
1 h after 0.047 0,046 0.091 0.612
24 h after 0.646 0,753 0.310 0.499

Results are shown as means ± SEM (SE – experimental group with suboptimal level of vitamin D, SC – control group with suboptimal level of vitamin D, OE – experimental group with optimal lever of vitamin D, OC – control group with optimal level of vitamin D); p (between groups) Kruskal-Wallis test; p (inside groups) Friedman test for dependent means; p (Test I vs Test II) Wilcoxon test